The Mayo subset study is a baseline study, cardiovascular risk parameters cardiovascular risk parameters in women before they were randomized to receive hormone replacement therapy or placebo in the kEEPS. The researchers divided the 118 women into three groups according to BMI, with women in the low, moderate, and high groups with BMI of less than 25 25 to 29 get information here read more .9 and 30 to 34, the researchers investigated conventional cardiovascular risk factors such as blood pressure, cholesterol, triglycerides, fasting blood glucose and liver function. They also analyzed the women’s blood for platelet count platelet reactivity, populations of activated cell membrane-derived thrombogenic microvesicles, and the amount of high – sensitivity C – reactive protein and activated protein C. Finally subjected the women – computer tomography scans to for testing the presence of calcium in their coronary arteries, an indicator of cardiovascular disease.
ResultsAlthough most of the conventional risk factors were in the normal range in all of of the women, the researchers found that these parameters the medium and high the middle and high BMI groups compared to the low BMI group. For example, the mean blood pressure in the low BMI group 115/72 mmHg, but 124/77 mmHg and 127/78 mmHg in the middle and high BMI group. Likewise, mean fasting blood glucose was 89 mg / dL in the low BMI group, but 92 mg / dl and 95 mg / dL in the medium and high BMI groups. The exception was LDL, which was normal in the low BMI group with a mean of 122 mg / dL, but borderline high in the middle and high BMI groups, each having a mean of 138 mg / dl and 140 mg / dl.
– SUMO proteins which Sentrin originally, which to other proteins and change their function or to physically move them within the cell .